Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Acacia Engineered Products.


Franklin, TN, March 20 (New Orleans)

The IsoBalance medical device that Acacia Engineered Products manufactures was declared both adulterated a·dul·ter·ate  
tr.v. a·dul·ter·at·ed, a·dul·ter·at·ing, a·dul·ter·ates
To make impure by adding extraneous, improper, or inferior ingredients.

adj.
1. Spurious; adulterated.

2. Adulterous.
 and misbranded mis·brand  
tr.v. mis·brand·ed, mis·brand·ing, mis·brands
To brand or label misleadingly or fraudulently.

Adj. 1.
 by FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 due to several violations.

FDA wrote that the company does not have an approved application for premarket approval (PMA) or for an investigational device exemption An Investigational Device Exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval (PMA) application or a Premarket Notification [510(k)] submission to Food and  (IDE.) The device is also misbranded because the company did not notify FDA of its intent to introduce the device into commercial distribution. The IsoBalance is misbranded because the device was manufactured, prepared, propagated, compounded or processed in an establishment not duly registered and the device was not included in a list as required.

FDA's inspection revealed that device is adulterated because of violations of GMP requirements of the Quality System (QS) regulation. The firm had failed to establish or implement the QS procedures required, FDA wrote. PMA; QC/QS
COPYRIGHT 2008 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:MEDICAL DEVICES
Publication:Warning Letter Bulletin
Date:Apr 1, 2008
Words:138
Previous Article:U.S. Apothecary Labs.
Next Article:Innovations for Access.



Related Articles
High-growth Acacia Networks announces new Lowell, Mass. worldwide headquarters; Networking switch vendor to add 30 new positions by end of 1996.
Acacia Research Affiliate Names Executive VP of Product Development and Files Additional Patent Applications.
Acacia Technologies Expands Patent Licensing and Engineering Teams.
Acacia Research Reports Third Quarter Financial Results.
Acacia Research Reports Fourth Quarter and Year End Financial Results.
Acacia Technologies Acquires Rights to Patent for Heated Surgical Blades.
S3 Acquires Acacia Semiconductor S.A.
Abyaar get Al Habtoor on-board for luxury Acacia Avenues project.
Acacia Subsidiary Acquires Rights to Patents for Laparoscopic Surgery Technology.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles